Bifidobacterium lactis BI-04 and Increased Probiotic Consumption

• Comparison of qRT-PCR and ddPCR for multi-strain probiotic detection after a randomized human clinical trial.

  • 2025-04-28
  • Clinical Trial
  • Frontiers in microbiology 16
  • • Nicolas Yeung
    • Arthur C Ouwehand

  • PubMed: 40356649
  • DOI: 10.3389/fmicb.2025.1579797

  3 Insights on

  • Increased Probiotic Consumption

  • Moderate evidence

  The ability to detect probiotic consumption during a human clinical trial is crucial to verify and validate placebo and verum groups in post hoc analysis... Moreover, we discovered that most of the sensitivity and specificity had come from a single assay alone (Bifidobacterium animalis subsp. lactis Bl-04).

  Effect

  Neutral

  Effect size

  Small